Evi Arthur

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial

08/08/2024

In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...

In July, Teva announced positive...

08/08/2024

Neurology

News

Continuing ADHD Treatment During Pregnancy May Help Patients Better Manage OUD

07/31/2024

Evi Arthur ;

Pregnant patients with comorbid ADHD and OUD who remain on their ADHD medications throughout pregnancy are more likely to adhere to OUD treatment and less likely to overdose than patients who stop taking ADHD medication, according to results...

Pregnant patients with comorbid...

07/31/2024

Psych Congress Network

News

FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment

07/29/2024

Evi Arthur ;

VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

VYVGART Hytrulo (efgartigimod...

07/29/2024

Neurology

News

One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says

07/22/2024

Evi Arthur ;

Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry.

Including non-specific effects,...

07/22/2024

Psych Congress Network

News

Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults

07/22/2024

Evi Arthur ;

Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine.

Chronic loneliness was...

07/22/2024

Neurology

News

Combining TMS or tDCS With Certain Medications May Reduce MDD Symptoms

07/16/2024

Evi Arthur ;

Combining certain medications or psychotherapy with TMS or tDCS may decrease symptoms of MDD, though some limitations still exist, according to a review published in the Harvard Review of Psychiatry.

Combining certain medications or...

07/16/2024

Psych Congress Network

News

Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C

07/16/2024

Evi Arthur ;

Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.

Children and adolescents with...

07/16/2024

Neurology

News

Video Game Treatment for Adults With ADHD Cleared by FDA

07/02/2024

Evi Arthur ;

AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.

AKL-T01 is indicated for adults...

07/02/2024

Psych Congress Network

News

Age-Dependent Association Found Between Cannabis Use and Psychosis

06/27/2024

Evi Arthur ;

Cannabis use was significantly associated with psychotic disorders during adolescence, but not during young adulthood, according to results from an observational study published in Psychological Medicine.

Cannabis use was significantly...

06/27/2024

Psych Congress Network